Enzymatica Overview

  • Founded
  • 2007
  • Status
  • Public
  • Employees
  • 24
  • Stock Symbol
  • ENZY
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $1.25
  • (As of Friday Closing)

Enzymatica General Information


Enzymatica AB is a life science company that develops and sells medical devices against infectious diseases, based on a barrier technology, which includes marine enzymes. Its product ColdZyme Mouth Spray prevents cold and reduces disease period.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Therapeutic Devices
Other Industries
Distributors (Healthcare)
Stock Exchange
Primary Office
  • Ideon Science Park
  • 223 70 Lund
  • Sweden
+46 046-286 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Enzymatica Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.25 $1.27 $1.04 - $2.70 $188M 149M 243K -$0.02

Enzymatica Financials Summary

In Thousands,
TTM 30-Jun-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 175,549 323,489 58,024 26,017
Revenue 10,906 12,065 6,482 6,041
EBITDA (3,499) (649) (3,669) (3,975)
Net Income (3,583) (1,434) (4,333) (4,894)
Total Assets 21,347 19,752 15,799 20,600
Total Debt 1,566 1,764 596 532
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Enzymatica Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Enzymatica‘s full profile, request access.

Request a free trial

Enzymatica Executive Team (12)

Name Title Board Seat Contact Info
Therese Filmersson Chief Financial Officer & Deputy CEO
Claus Egstrand Chief Operating Officer
Johan Lindvall CTO, EVP
Ulf Blom Co-Founder and Executive Vice President, Marketing & Operations
Jörgen Rexö Co-Founder
You’re viewing 5 of 12 executive team members. Get the full list »

Enzymatica Board Members (1)

Name Representing Role Since
00000 00000 Self Executive Chairman 000 0000
To view Enzymatica’s complete board members history, request access »

Enzymatica Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Enzymatica Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Enzymatica‘s full profile, request access.

Request a free trial

Enzymatica Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 01-Apr-2016 000000000000000000 00.00 Pharmaceuticals 0000000 00000000 00.0
To view Enzymatica’s complete acquisitions history, request access »

Enzymatica Subsidiaries (1)

Company Name Industry Location Founded
00000000 Pharmaceuticals Reykjavík, Iceland 0000
To view Enzymatica’s complete subsidiaries history, request access »